Evaluations Of HGEN-001 Formulation Indicate Capabilities For New Hair Follicle Creation And More Rapid Healing Post-Laser Resurfacing

Histogen Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today presented findings from preliminary evaluations of the Company’s HGEN-001 formulation, during International Investigative Dermatology 2008, taking place May 14-17, 2008 in Kyoto, Japan.

More: continued here

Filed under: Dermatology on May 22nd, 2008